Fundraising Fox
Cerapedics
Westminster, US · Delaware corporation · 3 known investors
Find your way into Cerapedics
Sign up to see every warm intro you have to Cerapedics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cerapedics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cerapedics develops P-15 peptide enhanced bone graft products, marketed as bone growth accelerators, for spinal fusion procedures. Its US FDA-approved products PearlMatrix (lumbar/TLIF) and i-FACTOR (cervical/ACDF) are used by surgeons for spine surgery.
Founders & leadership
BP
Britt PearsonPrincipal Consultant (via Veideland Consulting)2016–2017Executive Officer at Cerapedics, which develops FDA-approved bone graft products for spinal fusion procedures. Pearson has held leadership roles in finance, operations, and strategy across biotech, high-tech, and government sectors, with expertise in process optimization, financial controls, and regulatory compliance; she holds a CPA and a B.S. in Business and Accounting from the University of Oregon.
GK
Glen KashubaChief Executive Officer, Board Member2013–2022Glen Kashuba has held CEO positions at HIGHRIDGE Medical and Cerapedics, and served as Divisional President at Johnson & Johnson and Zimmer Biomet across orthopedics, neurosurgery, and cardiology markets, with over 38 years in medical devices.
AH
Andrew HandwerkerExecutive
PJ
Paul J. MrazExecutive
Board
JS
CK
Chau KhuongBoard directorAdvisory Board; Founder & Chief Investment Officer, CJNV BioVentures at Blackbird Bioventures
SS
Samuel S. WuBoard director
NK
Noah KroloffBoard director
KS
Ken S. AbramowitzBoard director
Investors · 3
Funding
SEC filings, press & company announcements$65M disclosed across 5 of 6 rounds · 2009–2022
- Undisclosed amountSeries BApr 2009
NGN Capital, OrbiMed Advisors, LLC
Source ↗
▶$25MraisedMar 2022 · 6 investors · BiotechnologyRule 506(b)
▶$25MraisedMar 2022 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nael KassarDirector
- Glen KashubaExecutive Officer, Director
- Ken AbramowitzDirector
- Antony KoblishDirector
- John TattoryExecutive Officer
- Greg GarfieldDirector
- Andrew J. TofeDirector
- Doug KohrsDirector
- Jeffrey G. MarxExecutive Officer
- Tyrell RiversDirector
- Valeska SchroederDirector
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22MraisedJul 2018 · 2 investors · BiotechnologyRule 506(b)
▶$22MraisedJul 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Glen KashubaExecutive Officer, Director
- Chau KhuongDirector
- Andrew J. TofeDirector
- Doug KohrsDirector
- Antony KoblishDirector
- Drew TrivisonnoExecutive Officer
- Tyrell RiversDirector
- Jeffrey G. MarxExecutive Officer
- Ken AbramowitzDirector
- Offering amount
- $22M
- Amount sold
- $22M
- Sales commissions
- $1.2M
- Placement agents
- Easterly Securities LLC
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedSep 2016 · 8 investors · BiotechnologyRule 506(b)
▶$11MraisedSep 2016 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Noah KroloffDirector
- Antony KoblishDirector
- Jonathan SilversteinDirector
- Britt PearsonExecutive Officer
- Andrew J. TofeDirector
- Jeff MarxExecutive Officer
- Glen KashubaExecutive Officer, Director
- Jerome ConnorExecutive Officer
- Chau KhuongDirector
- Samuel S. WuDirector
- Offering amount
- $14M
- Amount sold
- $11M
- Sales commissions
- $500K
- Placement agents
- Leerink Partners LLC
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedFeb 2015 · 5 investors · BiotechnologyRule 506(b)
▶$4MraisedFeb 2015 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew J. TofeDirector
- Britt PearsonExecutive Officer
- Jonathan SilversteinDirector
- Chau KhuongDirector
- Jeff MarxExecutive Officer
- Glen KashubaExecutive Officer, Director
- Samuel S. WuDirector
- Jerome ConnorExecutive Officer
- Noah KroloffDirector
- Antony KoblishDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedFeb 2012 · 3 investors · BiotechnologyRule 506(b)
▶$3MraisedFeb 2012 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan SilversteinDirector
- Chen SchorDirector
- Andrew J TofeDirector
- Ken S. AbramowitzDirector
- Andrew HandwerkerExecutive Officer
- Leonard HabasDirector
- Paul J. MrazExecutive Officer, Director
- Chau KhuongDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Cerapedics went on to found or lead other companies.
Related companies · 4
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
NuvasiveNuVasive provides intraoperative neuromonitoring (IONM) services and implantable orthopedic and spinal devices for hospitals, surgeons, and patients, supported by board-certified neurologists and neurophysiologists. The company is transitioning its operations to Globus Medical.
GenhealthGenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.
Globus MedicalGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Companies working in the same space as Cerapedics.
In the news
Frequently asked questions
- What does Cerapedics do?
- Cerapedics develops P-15 peptide enhanced bone graft products, marketed as bone growth accelerators, for spinal fusion procedures. Its US FDA-approved products PearlMatrix (lumbar/TLIF) and i-FACTOR (cervical/ACDF) are used by surgeons for spine surgery.
- Who founded Cerapedics?
- Cerapedics was founded by Andrew J. Tofe.
- Who are Cerapedics's investors?
- Cerapedics's investors include Revelation Partners, NGN Capital, OrbiMed.
- How much funding has Cerapedics raised?
- Cerapedics has disclosed $65M raised across 5 of its 6 known rounds.
- Where is Cerapedics headquartered?
- Cerapedics is headquartered in Westminster, US.